|
|
|
|
|
|
|
Soligenix Inc (SNGX)
|
|
1.71 -0.09 (-5%)
|
04-20 16:00
|
|
Open:
|
1.79
|
Pre. Close:
|
1.8
|
|
High:
|
1.79
|
Low:
|
1.6995
|
|
Volume:
|
12,138
|
Market Cap:
|
15M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.793 - 1.802
|
1.802 - 1.809
|
|
Low:
|
1.68 - 1.689
|
1.689 - 1.697
|
|
Close:
|
1.696 - 1.711
|
1.711 - 1.723
|
|
|
|
Technical analysis (as of: 2018-04-20 4:33:41 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 3.38 One year: 4.32
|
|
Support:
|
Support1: 1.60 Support2: 1.33
|
|
Resistance:
|
Resistance1:
2.90 Resistance2: 3.70
|
|
Pivot:
|
1.81 
|
|
Moving Averages:
|
MA(5): 1.76 MA(20): 1.85
MA(100): 2.04 MA(250): 2.19
|
|
MACD:
|
MACD(12,26):
-0.07 Signal(12,26,9): -0.06
|
|
%K %D:
|
%K(14,3): 35.19 %D(3): 35.47 
|
|
RSI:
|
RSI(14): 37.03
|
|
52-Week:
|
High: 4.4
Low: 1.6 Change(%): -56.5
|
|
Average Vol(K):
|
3-Month: 15995
10-Days 2814
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.SNGX has closed above bottom band by 8.3%. Bollinger Bands are 19.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-03-23T00:49:21-04:00
Your Daily Pharma Scoop: Omeros' Omidria, Titan Signs Agreement, Reata Announces Top-Line Results
2018-03-22T12:45:06-04:00
Midday Gainers / Losers (03/22/2018)
2018-03-22T09:11:54-04:00
Premarket Gainers as of 9:05 am (03/22/2018)
2018-03-22T06:58:43-04:00
Soligenix's RiVax an Orphan Drug in Europe
2018-03-22T06:00:00-04:00
Soligenix Receives Orphan Drug Designation from the European Commission for RiVax® for Prevention of Ricin Poisoning
2018-03-15T06:07:20-04:00
Soligenix reports FY results
2018-03-15T06:00:00-04:00
Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results
2018-03-13T06:00:00-04:00
Soligenix to Present at the 12th Annual International Partnering Conference Bio-Europe Spring
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
